UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A Small-Molecule Anti-secretagogue of PCSK9 Targets the 80S Ribosome to Inhibit PCSK9 Protein Translation

Cell chemical biology, 2016-11, Vol.23 (11), p.1362-1371

2016

Volltextzugriff (PDF)

Improving on Nature: Making a Cyclic Heptapeptide Orally Bioavailable

Angewandte Chemie (International ed.), 2014-11, Vol.53 (45), p.12059-12063

International ed. in English, 2014

Volltextzugriff (PDF)

A potentiator of orthosteric ligand activity at GLP-1R acts via covalent modification

Nature chemical biology, 2014-08, Vol.10 (8), p.629

2014

Volltextzugriff (PDF)

Intestinal targeting of drugs: rational design approaches and challenges

Current topics in medicinal chemistry, 2013-04, Vol.13 (7), p.776

2013

Volltextzugriff (PDF)

Description of the torcetrapib series of cholesteryl ester transfer protein inhibitors, including mechanism of action

Journal of lipid research, 2006-03, Vol.47 (3), p.537-552

2006

Volltextzugriff (PDF)

In silico modeling of nonspecific binding to human liver microsomes

Drug metabolism and disposition, 2008-10, Vol.36 (10), p.2130

2008

Volltextzugriff (PDF)

A Small-Molecule Oral Agonist of the Human Glucagon-like Peptide‑1 Receptor

Journal of medicinal chemistry, 2022-06, Vol.65 (12), p.8208-8226

2022

Volltextzugriff (PDF)

Bioorthogonal Tethering Enhances Drug Fragment Affinity for G Protein-Coupled Receptors in Live Cells

Journal of the American Chemical Society, 2023-05, Vol.145 (20), p.11173-11184

2023

Volltextzugriff (PDF)

6-Azaspiro[2.5]octanes as small molecule agonists of the human glucagon-like peptide-1 receptor

Bioorganic & medicinal chemistry letters, 2023-10, Vol.94, p.129454-129454, Article 129454

2023

Volltextzugriff (PDF)

Small molecule inhibitors of PCSK9. SAR investigations of head and amine groups

Bioorganic & medicinal chemistry letters, 2023-08, Vol.92, p.129394-129394, Article 129394

2023

Volltextzugriff (PDF)

Liver‐Targeted Small‐Molecule Inhibitors of Proprotein Convertase Subtilisin/Kexin Type 9 Synthesis

Angewandte Chemie International Edition, 2017-12, Vol.56 (51), p.16218-16222

International ed. in English, 2017

Volltextzugriff (PDF)

Crystal Structures of Cholesteryl Ester Transfer Protein in Complex with Inhibitors

The Journal of biological chemistry, 2012-10, Vol.287 (44), p.37321-37329

2012

Volltextzugriff (PDF)

Raising high-density lipoprotein in humans through inhibition of cholesteryl ester transfer protein: an initial multidose study of torcetrapib

Arteriosclerosis, thrombosis, and vascular biology, 2004-03, Vol.24 (3), p.490

2004

Volltextzugriff (PDF)

Mechanistic Characterization of a 2‑Thioxanthine Myeloperoxidase Inhibitor and Selectivity Assessment Utilizing Click Chemistry–Activity-Based Protein Profiling

Biochemistry (Easton), 2013-12, Vol.52 (51), p.9187-9201

2013

Volltextzugriff (PDF)

Synthesis of the CETP Inhibitor Torcetrapib: The Resolution Route and Origin of Stereoselectivity in the Iminium Ion Cyclization

Organic process research & development, 2006-05, Vol.10 (3), p.464-471

2006

Volltextzugriff (PDF)

Discovery of N-(piperidin-3-yl)-N-(pyridin-2-yl)piperidine/piperazine-1-carboxamides as small molecule inhibitors of PCSK9

Bioorganic & medicinal chemistry letters, 2018-12, Vol.28 (23-24), p.3685-3688

2018

Volltextzugriff (PDF)

Comparative pharmacokinetic profile of cyclosporine (CsA) with a decapeptide and a linear analogue

Organic & biomolecular chemistry, 2017-03, Vol.15 (12), p.2501-2506

2017

Volltextzugriff (PDF)

A Strategy for the Solid-Phase Synthesis of Oligosaccharides

Science (American Association for the Advancement of Science), 1993-05, Vol.260 (5112), p.1307-1309

1993

Volltextzugriff (PDF)

Species Differences in the Oxidative Desulfurization of a Thiouracil-Based Irreversible Myeloperoxidase Inactivator by Flavin-Containing Monooxygenase Enzymes

Drug metabolism and disposition, 2016-08, Vol.44 (8), p.1262-1269

2016

Volltextzugriff (PDF)

Cyclic alpha-conotoxin peptidomimetic chimeras as potent GLP-1R agonists

European journal of medicinal chemistry, 2015-10, Vol.103, p.175-184

2015

Volltextzugriff (PDF)

Truncated Glucagon-like Peptide-1 and Exendin-4 α-Conotoxin pl14a Peptide Chimeras Maintain Potency and α-Helicity and Reveal Interactions Vital for cAMP Signaling in Vitro

The Journal of biological chemistry, 2016-07, Vol.291 (30), p.15778-15787

2016

Volltextzugriff (PDF)

Daphniphyllum Alkaloids. 16. Total Synthesis of (+)-Codaphniphylline

Journal of organic chemistry, 1995-03, Vol.60 (5), p.1120-1130

1995

Volltextzugriff (PDF)

Cyclic Penta- and Hexaleucine Peptides without N‑Methylation Are Orally Absorbed

ACS medicinal chemistry letters, 2014-10, Vol.5 (10), p.1148-1151

2014

Volltextzugriff (PDF)

1 – 25 von 61

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(59)
Mit Volltextzugriff
(55)

Publikationsform

Artikel
(60)
Buchkapitel
(1)

Sprache

Englisch
(61)
Japanisch
(15)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A Small-Molecule Anti-secretagogue of PCSK9 Targets the 80S Ribosome to Inhibit PCSK9 Protein Translation

Improving on Nature: Making a Cyclic Heptapeptide Orally Bioavailable

A potentiator of orthosteric ligand activity at GLP-1R acts via covalent modification

Intestinal targeting of drugs: rational design approaches and challenges

Description of the torcetrapib series of cholesteryl ester transfer protein inhibitors, including mechanism of action

In silico modeling of nonspecific binding to human liver microsomes

A Small-Molecule Oral Agonist of the Human Glucagon-like Peptide‑1 Receptor

Bioorthogonal Tethering Enhances Drug Fragment Affinity for G Protein-Coupled Receptors in Live Cells

6-Azaspiro[2.5]octanes as small molecule agonists of the human glucagon-like peptide-1 receptor

Discovery of High-Affinity Small-Molecule Binders of the Epigenetic Reader YEATS4

Small molecule inhibitors of PCSK9. SAR investigations of head and amine groups

Liver‐Targeted Small‐Molecule Inhibitors of Proprotein Convertase Subtilisin/Kexin Type 9 Synthesis

Crystal Structures of Cholesteryl Ester Transfer Protein in Complex with Inhibitors

Raising high-density lipoprotein in humans through inhibition of cholesteryl ester transfer protein: an initial multidose study of torcetrapib

Mechanistic Characterization of a 2‑Thioxanthine Myeloperoxidase Inhibitor and Selectivity Assessment Utilizing Click Chemistry–Activity-Based Protein Profiling

Synthesis of the CETP Inhibitor Torcetrapib: The Resolution Route and Origin of Stereoselectivity in the Iminium Ion Cyclization

Discovery of N-(piperidin-3-yl)-N-(pyridin-2-yl)piperidine/piperazine-1-carboxamides as small molecule inhibitors of PCSK9

Comparative pharmacokinetic profile of cyclosporine (CsA) with a decapeptide and a linear analogue

A Strategy for the Solid-Phase Synthesis of Oligosaccharides

Discovery of 2‑(6-(5-Chloro-2-methoxyphenyl)-4-oxo-2-thioxo-3,4-dihydropyrimidin-1(2H)‑yl)acetamide (PF-06282999): A Highly Selective Mechanism-Based Myeloperoxidase Inhibitor for the Treatment of Cardiovascular Diseases

Species Differences in the Oxidative Desulfurization of a Thiouracil-Based Irreversible Myeloperoxidase Inactivator by Flavin-Containing Monooxygenase Enzymes

Cyclic alpha-conotoxin peptidomimetic chimeras as potent GLP-1R agonists

Truncated Glucagon-like Peptide-1 and Exendin-4 α-Conotoxin pl14a Peptide Chimeras Maintain Potency and α-Helicity and Reveal Interactions Vital for cAMP Signaling in Vitro

Daphniphyllum Alkaloids. 16. Total Synthesis of (+)-Codaphniphylline

Cyclic Penta- and Hexaleucine Peptides without N‑Methylation Are Orally Absorbed

Suchergebnisse filtern